BioXcel Therapeutics (BTAI) Q4 2025 Earnings

Nov 12Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-6.04
-4.48
-2.91
-1.34

Details

Expected EPS
-1.34
Actual EPS
-2.18
Surprise EPS
-0.84
Surprise Percent
-62.69%

Description

⁨BioXcel Therapeutics⁩ (⁦BTAI⁩) has reported earnings of ⁦-2.18⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts